Efficacy of Different Doses of Tai Chi Chuan on Cognitive Function in Persons With Mild Cognitive Impairment
NCT06375720, Not applicable, Unknown, Lidian Chen
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Efficacy of Different Doses of Tai Chi Chuan on Cognitive Function in Persons With Mild Cognitive Impairment | ClinicalTrials.gov |
| NCT number | NCT06375720 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 350 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Lidian Chen | ClinicalTrials.gov |
| Conditions | Mild Cognitive Impairment | ClinicalTrials.gov |
| Interventions | Lower frequency, shorter period of Tai Chi Chuan, Higher frequency, shorter period of Tai Chi Chuan, Lower frequency, longer period of Tai Chi Chuan, Higher frequency, longer period of Tai Chi Chuan, Standard Health Education | ClinicalTrials.gov |
| First posted | 2024-04-19 | ClinicalTrials.gov |
| Last updated | 2024-04-19 | ClinicalTrials.gov |
Registered outcomes 17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Montreal Cognitive Assessment | 12 weeks, 24 weeks | Global cognition | ClinicalTrials.gov |
| Secondary | Montreal Cognitive Assessment | 52 weeks | Global cognition | ClinicalTrials.gov |
| Secondary | Wechsler Memory Scale | 12 weeks, 24 weeks and 52 weeks | Memory function | ClinicalTrials.gov |
| Secondary | Digit Symbol Substitution Test | 12 weeks, 24 weeks and 52 weeks | Attention | ClinicalTrials.gov |
| Secondary | Trial Making Test part B | 12 weeks, 24 weeks and 52 weeks | Executive Function | ClinicalTrials.gov |
| Secondary | Stroop Color Word Test | 12 weeks, 24 weeks and 52 weeks | Processing Speed | ClinicalTrials.gov |
| Secondary | Boston Naming Test | 12 weeks, 24 weeks and 52 weeks | Verbal fluency | ClinicalTrials.gov |
| Secondary | Rey-Osterrieth Complex Graphics Test | 12 weeks, 24 weeks and 52 weeks | Visuo-spatial ability | ClinicalTrials.gov |
| Secondary | Rey Auditory Verbal Learning Test | 12 weeks, 24 weeks and 52 weeks | Episodic memory | ClinicalTrials.gov |
| Other | The Pittsburgh Sleep Quality Index (PSQI) | 12 weeks, 24 weeks and 52 weeks | Sleep quality | ClinicalTrials.gov |
| Other | 12-Item Short Form Health Survey | 12 weeks, 24 weeks and 52 weeks | General health | ClinicalTrials.gov |
| Other | Blood glucose metabolism index | 12 weeks, 24 weeks and 52 weeks | fasting blood glucose | ClinicalTrials.gov |
| Other | Blood lipid metabolism index | 12 weeks, 24 weeks and 52 weeks | total cholesterol (TC); total triglyceride (TG); low density lipoprotein (LDL);high density lipoprotein (HDL) | ClinicalTrials.gov |
| Other | functional Magnetic Resonance Imaging | 12 weeks or 24 weeks [post-intervention] | functional Magnetic Resonance Imaging | ClinicalTrials.gov |
| Other | Electroencephalogram | 12 weeks or 24 weeks [post-intervention] | The power spectrum density of the brain in a relaxed state is measured using a resting-state electroencephalogram (EEG) for the delta (1-4 Hz), theta (4-8 Hz), alpha (8-13 Hz), beta (13-30 Hz), and gamma (30-100 Hz) bands. | ClinicalTrials.gov |
| Other | Heart rate variability | 12 weeks or 24 weeks [post-intervention] | Cardiac autonomic modulations | ClinicalTrials.gov |
| Other | Gut microflora | 12 weeks, 24 weeks and 52 weeks | 16S rRNA amplification sequencing was used to detect intestinal microbiota. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Picture Naming Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Symbol Coding | Secondary outcome | ConductCognition |
| Verbal Fluency | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)